NCT06115681
- Conditions
- Dedifferentiated Liposarcoma, Liposarcoma, Neoplasms, +4 more
- Locations
-
- Beijing Jishuitan hospital Beijing, China
Clinical trial condition
Neoplasms, Adipose Tissue
Explore clinical trials studying Neoplasms, Adipose Tissue. Study availability and eligibility vary by location and protocol.
167 public trials
35 recruiting studies
Neoplasms, Adipose Tissue trial results
Completed
Adrenal Myelolipomas Case Series
NCT06913842
- Conditions
- Adrenal Myelolipoma, Myelolipoma, Neoplasms, +3 more
- Locations
-
- Mexican Social Security Institute: Regional General Hospital No. 1 Mérida, Yucatán, Mexico
NCT02249949
- Conditions
- Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of Colorado Hospital Aurora, Colorado, United States
- Yale University New Haven, Connecticut, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
NCT04028479
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
- Locations
-
- Teton Cancer Institute Idaho Falls, Idaho, United States
- Oncology and Hematology of South Texas Laredo, Texas, United States
NCT02978859
- Conditions
- Liposarcoma, Metastatic Liposarcoma, Neoplasms, +4 more
- Locations
-
- Massachussetts General Hospital Boston, Massachusetts, United States
- Washington University St Louis, Missouri, United States
- Columbia University Irving Medical Center New York, United States
Completed
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
NCT02048371
- Conditions
- Chondrosarcoma, Chondrosarcoma, Mesenchymal, Ewing/Ewing-like Sarcoma, +14 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Sarcoma Oncology Research Center Santa Monica, California, United States
- Stanford University Stanford, California, United States
Completed
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
NCT02584309
- Conditions
- Angiosarcoma, Dermatofibrosarcoma, Epithelioid Sarcoma, +31 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT03063632
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +33 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT02500797
- Conditions
- Bone Diseases, Bone Neoplasms, Histiocytoma, +32 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT03450122
- Conditions
- HLA-A*0201 Positive Cells Present, Liposarcoma, Liposarcoma, Myxoid, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States